Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Filtered Trial for Telmisartan 40mg Non-responder.

Trial Profile

Filtered Trial for Telmisartan 40mg Non-responder.

Phase of Trial: Phase III

Latest Information Update: 12 Dec 2013

At a glance

  • Drugs Amlodipine/telmisartan (Primary) ; Telmisartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 08 Oct 2008 Actual patient number (314) added as reported by ClinicalTrials.gov.
    • 08 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Jul 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top